OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenges facing adjuvants for cancer immunotherapy
Circe Mesa, Luis E. Fernández
Immunology and Cell Biology (2004) Vol. 82, Iss. 6, pp. 644-650
Open Access | Times Cited: 82
Circe Mesa, Luis E. Fernández
Immunology and Cell Biology (2004) Vol. 82, Iss. 6, pp. 644-650
Open Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
Squalene: A natural triterpene for use in disease management and therapy
L. Harivardhan Reddy, Patrick Couvreur
Advanced Drug Delivery Reviews (2009) Vol. 61, Iss. 15, pp. 1412-1426
Closed Access | Times Cited: 352
L. Harivardhan Reddy, Patrick Couvreur
Advanced Drug Delivery Reviews (2009) Vol. 61, Iss. 15, pp. 1412-1426
Closed Access | Times Cited: 352
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Yvonne Perrie, Afzal R. Mohammed, Daniel Kirby, et al.
International Journal of Pharmaceutics (2008) Vol. 364, Iss. 2, pp. 272-280
Closed Access | Times Cited: 326
Yvonne Perrie, Afzal R. Mohammed, Daniel Kirby, et al.
International Journal of Pharmaceutics (2008) Vol. 364, Iss. 2, pp. 272-280
Closed Access | Times Cited: 326
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Samar Hamdy, Azita Haddadi, Ryan Hung, et al.
Advanced Drug Delivery Reviews (2011) Vol. 63, Iss. 10-11, pp. 943-955
Closed Access | Times Cited: 281
Samar Hamdy, Azita Haddadi, Ryan Hung, et al.
Advanced Drug Delivery Reviews (2011) Vol. 63, Iss. 10-11, pp. 943-955
Closed Access | Times Cited: 281
Nanomaterials for cancer immunotherapy
Wantong Song, Sara Musetti, Leaf Huang
Biomaterials (2017) Vol. 148, pp. 16-30
Open Access | Times Cited: 252
Wantong Song, Sara Musetti, Leaf Huang
Biomaterials (2017) Vol. 148, pp. 16-30
Open Access | Times Cited: 252
Metallic nanoparticles for cancer immunotherapy
Emily Evans, Pallavi Bugga, Vishwaratn Asthana, et al.
Materials Today (2017) Vol. 21, Iss. 6, pp. 673-685
Open Access | Times Cited: 205
Emily Evans, Pallavi Bugga, Vishwaratn Asthana, et al.
Materials Today (2017) Vol. 21, Iss. 6, pp. 673-685
Open Access | Times Cited: 205
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 53
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 53
Delivering metal ions by nanomaterials: Turning metal ions into drug-like cancer theranostic agents
Chenguang Liu, Lingxiao Guo, Yong Wang, et al.
Coordination Chemistry Reviews (2023) Vol. 494, pp. 215332-215332
Closed Access | Times Cited: 47
Chenguang Liu, Lingxiao Guo, Yong Wang, et al.
Coordination Chemistry Reviews (2023) Vol. 494, pp. 215332-215332
Closed Access | Times Cited: 47
Nanoparticles and microparticles as vaccine-delivery systems
Manmohan Singh, Aravind Chakrapani, Derek T. O’Hagan
Expert Review of Vaccines (2007) Vol. 6, Iss. 5, pp. 797-808
Closed Access | Times Cited: 253
Manmohan Singh, Aravind Chakrapani, Derek T. O’Hagan
Expert Review of Vaccines (2007) Vol. 6, Iss. 5, pp. 797-808
Closed Access | Times Cited: 253
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity
Samar Hamdy, Ommoleila Molavi, Zengshuan Ma, et al.
Vaccine (2008) Vol. 26, Iss. 39, pp. 5046-5057
Closed Access | Times Cited: 248
Samar Hamdy, Ommoleila Molavi, Zengshuan Ma, et al.
Vaccine (2008) Vol. 26, Iss. 39, pp. 5046-5057
Closed Access | Times Cited: 248
Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes
Karen Zaks, Michael B. Jordan, Amanda Guth, et al.
The Journal of Immunology (2006) Vol. 176, Iss. 12, pp. 7335-7345
Open Access | Times Cited: 238
Karen Zaks, Michael B. Jordan, Amanda Guth, et al.
The Journal of Immunology (2006) Vol. 176, Iss. 12, pp. 7335-7345
Open Access | Times Cited: 238
TGF‐β: a mobile purveyor of immune privilege
Sharon M. Wahl, Jie Wen, Niki M. Moutsopoulos
Immunological Reviews (2006) Vol. 213, Iss. 1, pp. 213-227
Open Access | Times Cited: 229
Sharon M. Wahl, Jie Wen, Niki M. Moutsopoulos
Immunological Reviews (2006) Vol. 213, Iss. 1, pp. 213-227
Open Access | Times Cited: 229
Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells
Angelica Loskog, Valeria Giandomenico, Claudia Rössig, et al.
Leukemia (2006) Vol. 20, Iss. 10, pp. 1819-1828
Closed Access | Times Cited: 190
Angelica Loskog, Valeria Giandomenico, Claudia Rössig, et al.
Leukemia (2006) Vol. 20, Iss. 10, pp. 1819-1828
Closed Access | Times Cited: 190
MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents
Ilaria Peluso, Nagendra Sastry Yarla, Roberto Ambra, et al.
Seminars in Cancer Biology (2017) Vol. 56, pp. 185-195
Closed Access | Times Cited: 146
Ilaria Peluso, Nagendra Sastry Yarla, Roberto Ambra, et al.
Seminars in Cancer Biology (2017) Vol. 56, pp. 185-195
Closed Access | Times Cited: 146
Dendritic cell therapy in cancer treatment; the state-of-the-art
Mahsa Sadeghzadeh, Soghra Bornehdeli, Haniye Mohahammadrezakhani, et al.
Life Sciences (2020) Vol. 254, pp. 117580-117580
Closed Access | Times Cited: 132
Mahsa Sadeghzadeh, Soghra Bornehdeli, Haniye Mohahammadrezakhani, et al.
Life Sciences (2020) Vol. 254, pp. 117580-117580
Closed Access | Times Cited: 132
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
Wenxue Ma, Chen, Kaushal, et al.
International Journal of Nanomedicine (2012), pp. 1475-1475
Open Access | Times Cited: 111
Wenxue Ma, Chen, Kaushal, et al.
International Journal of Nanomedicine (2012), pp. 1475-1475
Open Access | Times Cited: 111
Developments in Carbohydrate-Based Cancer Therapeutics
Farzana Hossain, Peter R. Andreana
Pharmaceuticals (2019) Vol. 12, Iss. 2, pp. 84-84
Open Access | Times Cited: 97
Farzana Hossain, Peter R. Andreana
Pharmaceuticals (2019) Vol. 12, Iss. 2, pp. 84-84
Open Access | Times Cited: 97
Towards a Self‐Adjuvanting Multivalent B and T cell Epitope Containing Synthetic Glycolipopeptide Cancer Vaccine
Olivier Renaudet, Lbachir BenMohamed, Gargi Dasgupta, et al.
ChemMedChem (2008) Vol. 3, Iss. 5, pp. 737-741
Closed Access | Times Cited: 101
Olivier Renaudet, Lbachir BenMohamed, Gargi Dasgupta, et al.
ChemMedChem (2008) Vol. 3, Iss. 5, pp. 737-741
Closed Access | Times Cited: 101
Polymeric micro- and nanoparticles for immune modulation
Elana Ben‐Akiva, Savannah Est-Witte, Randall A. Meyer, et al.
Biomaterials Science (2018) Vol. 7, Iss. 1, pp. 14-30
Open Access | Times Cited: 75
Elana Ben‐Akiva, Savannah Est-Witte, Randall A. Meyer, et al.
Biomaterials Science (2018) Vol. 7, Iss. 1, pp. 14-30
Open Access | Times Cited: 75
InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity
Feifan Zhou, Xiaosong Li, Mark F. Naylor, et al.
Cancer Letters (2015) Vol. 359, Iss. 2, pp. 169-177
Open Access | Times Cited: 71
Feifan Zhou, Xiaosong Li, Mark F. Naylor, et al.
Cancer Letters (2015) Vol. 359, Iss. 2, pp. 169-177
Open Access | Times Cited: 71
Nanoparticle mediated cancer immunotherapy
Jyoti Gupta, Haaris A. Safdari, Mehboob Hoque
Seminars in Cancer Biology (2020) Vol. 69, pp. 307-324
Closed Access | Times Cited: 67
Jyoti Gupta, Haaris A. Safdari, Mehboob Hoque
Seminars in Cancer Biology (2020) Vol. 69, pp. 307-324
Closed Access | Times Cited: 67
Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives
Ali Nazarizadeh, Alexander H. Staudacher, Nicole L. Wittwer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4707-4707
Open Access | Times Cited: 30
Ali Nazarizadeh, Alexander H. Staudacher, Nicole L. Wittwer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4707-4707
Open Access | Times Cited: 30
Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes
Ilham Bettahi, Gargi Dasgupta, Olivier Renaudet, et al.
Cancer Immunology Immunotherapy (2008) Vol. 58, Iss. 2, pp. 187-200
Open Access | Times Cited: 75
Ilham Bettahi, Gargi Dasgupta, Olivier Renaudet, et al.
Cancer Immunology Immunotherapy (2008) Vol. 58, Iss. 2, pp. 187-200
Open Access | Times Cited: 75
Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity
Olivier Renaudet, Gargi Dasgupta, Ilham Bettahi, et al.
PLoS ONE (2010) Vol. 5, Iss. 6, pp. e11216-e11216
Open Access | Times Cited: 73
Olivier Renaudet, Gargi Dasgupta, Ilham Bettahi, et al.
PLoS ONE (2010) Vol. 5, Iss. 6, pp. e11216-e11216
Open Access | Times Cited: 73
Immunotherapeutic approaches for cancer therapy: An updated review
Tohid Kazemi, Vahid Younesi, Farhad Jadidi‐Niaragh, et al.
Artificial Cells Nanomedicine and Biotechnology (2015), pp. 1-11
Closed Access | Times Cited: 63
Tohid Kazemi, Vahid Younesi, Farhad Jadidi‐Niaragh, et al.
Artificial Cells Nanomedicine and Biotechnology (2015), pp. 1-11
Closed Access | Times Cited: 63
Medical use of squalene as a natural antioxidant
F GNES
Journal of Marmara University Institute of Health Sciences (2013), pp. 1-1
Closed Access | Times Cited: 60
F GNES
Journal of Marmara University Institute of Health Sciences (2013), pp. 1-1
Closed Access | Times Cited: 60
